<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Med Surg (Lond)</journal-id><journal-id journal-id-type="iso-abbrev">Ann Med Surg (Lond)</journal-id><journal-title-group><journal-title>Annals of Medicine and Surgery</journal-title></journal-title-group><issn pub-type="epub">2049-0801</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25568780</article-id><article-id pub-id-type="pmc">4268478</article-id><article-id pub-id-type="publisher-id">S2049-0801(14)00025-9</article-id><article-id pub-id-type="doi">10.1016/j.amsu.2014.03.001</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>The effects of QuikClot Combat Gauze on hemorrhage control in the presence of hemodilution and hypothermia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Johnson</surname><given-names>Don</given-names></name><email>arthurjohnso@gmail.com</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><contrib contrib-type="author"><name><surname>Bates</surname><given-names>Sheri</given-names></name><email>washington.s@husky.neu.edu</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Nukalo</surname><given-names>Sofiya</given-names></name><email>nukalo.s@husky.neu.edu</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Staub</surname><given-names>Amy</given-names></name><email>staub.a@husky.neu.edu</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Hines</surname><given-names>Aaron</given-names></name><email>hines.a@husky.neu.edu</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Leishman</surname><given-names>Taylor</given-names></name><email>leischman.t@husky.neu.edu</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Michel</surname><given-names>Jennifer</given-names></name><email>michel.jen@husky.neu.edu</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Sikes</surname><given-names>Dusti</given-names></name><email>wilson.du@husky.neu.edu</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Gegel</surname><given-names>Brian</given-names></name><email>brian.gegel@vaspllc.com</email><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Burgert</surname><given-names>James</given-names></name><email>jburgert@sbcglobal.net</email><xref rid="aff1" ref-type="aff">a</xref></contrib></contrib-group><aff id="aff1"><label>a</label>US Army Graduate Program in Anesthesia, Department of the Army, Academy of Health Sciences, 3490 Forage Road, Fort Sam Houston, TX 78234-6130, USA</aff><aff id="aff2"><label>b</label>Veteran Anesthesia Services, PLLC, San Antonio, TX 78269, USA</aff><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author. Tel.:&#x000a0;+1 210 849 7364. <email>arthurjohnso@gmail.com</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>26</day><month>3</month><year>2014</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><month>6</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>26</day><month>3</month><year>2014</year></pub-date><volume>3</volume><issue>2</issue><fpage>21</fpage><lpage>25</lpage><history><date date-type="received"><day>19</day><month>12</month><year>2013</year></date><date date-type="rev-recd"><day>21</day><month>2</month><year>2014</year></date><date date-type="accepted"><day>2</day><month>3</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; 2014 The Authors</copyright-statement><copyright-year>2014</copyright-year><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).</license-p></license></permissions><abstract><p>Hemorrhage is the leading cause of death from trauma. Intravenous (IV) fluid resuscitation in these patients may cause hemodilution and secondary hemorrhage. In addition, hypothermia may interfere with coagulation. The purposes of this study were to compare the effectiveness QuikClot Combat Gauze (QCG) to a control group on hemorrhage in a hemodiluted, hypothermic model, and to determine the effects of IV volume resuscitation on rebleeding. This was a prospective, between subjects, experimental design. Yorkshire swine were randomly assigned to two groups: QCG (<italic>n</italic>&#x000a0;=&#x000a0;13) or control (<italic>n</italic>&#x000a0;=&#x000a0;13). The subjects were anesthetized. Hypothermia (temperature of &#x02264;34.0&#x000a0;&#x000b0;C) was induced; 30% of their blood volume was exsanguinated. A 3:1 replacement of Lactated Ringer's was administered to dilute the remaining blood. The femoral artery and vein were transected. After 1&#x000a0;min of uncontrolled hemorrhage, QCG was placed into the wound followed by standard wound packing. The control group underwent the same procedures without QCG. After 5&#x000a0;min of manual pressure, a pressure dressing was applied. Following 30&#x000a0;min, the dressings were removed, and blood loss was calculated. For subjects achieving hemostasis, up to 5&#x000a0;L of IV fluid was administered or until bleeding occurred, which was defined as &#x0003e;2% total blood volume. The QCG had significantly less hemorrhage than the control (QCG&#x000a0;=&#x000a0;30&#x000a0;&#x000b1;&#x000a0;99&#x000a0;mL; control&#x000a0;=&#x000a0;404&#x000a0;&#x000b1;&#x000a0;406&#x000a0;mL) (<italic>p</italic>&#x000a0;=&#x000a0;.004). Further, the QCG group was able to tolerate more resuscitation fluid before hemorrhage (QCG&#x000a0;=&#x000a0;4615&#x000a0;&#x000b1;&#x000a0;1386&#x000a0;mL; control&#x000a0;=&#x000a0;846&#x000a0;&#x000b1;&#x000a0;1836) (<italic>p</italic>&#x000a0;=&#x000a0;.000).</p></abstract><kwd-group><title>Keywords</title><kwd>Hemorrhage</kwd><kwd>Hemorrhage control</kwd><kwd>Shock</kwd><kwd>Hypothermia</kwd><kwd>Resuscitation</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1"><label>1</label><title>Introduction</title><p>Trauma is the leading cause of morbidity and mortality in both civilian and military populations with uncontrolled hemorrhage as the major cause of death <xref rid="bib1 bib2 bib3 bib4 bib5" ref-type="bibr">[1&#x02013;5]</xref>. During the recent conflicts in Iraq and Afghanistan, uncontrolled hemorrhage accounted for nearly 50% of battlefield deaths prior to evacuation <xref rid="bib6" ref-type="bibr">[6]</xref>. Trauma continues exceeds all of the other causes of death combined in persons younger than 36 years of age <xref rid="bib7" ref-type="bibr">[7]</xref>. Furthermore, significant blood loss predisposes individuals to hypothermia, coagulopathy, infection, acidosis and multiple organ failure. Therefore, early control of hemorrhage is essential for initial survival and also for optimal recovery <xref rid="bib8" ref-type="bibr">[8]</xref>. The US military's Committee on Tactical Combat Casualty Care (CTCCC) is the group responsible for developing guidelines for the management of wounded military personnel. CTCCC recommends QuikClot Combat Gauze (QCG) (Z-Medica, Wallingford, CT) as the first-line hemostatic agent for use in treatment of severe hemorrhage that cannot be controlled by a tourniquet <xref rid="bib9" ref-type="bibr">[9]</xref>. QCG is a kaolin-impregnated rayon/polyester hemostatic dressing that promotes clotting by activation of factor XII (FXII) and factor XI (FXI) of the intrinsic coagulation pathway <xref rid="bib10" ref-type="bibr">[10]</xref>.</p><p>QCG has been found to be effective in controlling massive hemorrhage in normothermic swine. <xref rid="bib11 bib12 bib13 bib14 bib15 bib16 bib17 bib18 bib19 bib20" ref-type="bibr">[11&#x02013;20]</xref> However, 30%&#x02013;50% of trauma patients present with hypothermic <xref rid="bib21 bib22" ref-type="bibr">[21,22]</xref>. This is problematic because hypothermia impairs coagulation. In a retrospective 12-month analysis, Arthurs found that 18% of combat trauma patient admitted at the 31st Combat Support Hospital in Iraq were hypothermic (temperature&#x000a0;&#x0003c;&#x000a0;36&#x000a0;&#x000b0;C) <xref rid="bib23" ref-type="bibr">[23]</xref>. Limited data exist relative to the effectiveness of hemostatic agents when the patient is hypothermic. Gegel and colleagues investigated the effectiveness of QCG in a hypothermic, porcine model and found that the agent was effective compared to a standard pressure dressing control <xref rid="bib24" ref-type="bibr">[24]</xref>.</p><p>Trauma and shock with systemic hypoperfusion are probably responsible for the development of coagulopathy <xref rid="bib7" ref-type="bibr">[7]</xref>. Acidosis is a common occurrence in trauma leading to impairment of the function of plasma proteases and to an increased degradation of fibrinogen <xref rid="bib7" ref-type="bibr">[7]</xref>. Furthermore, fluid resuscitation may dilute the clotting factors <xref rid="bib7" ref-type="bibr">[7]</xref>; therefore, hemodilution may influence the effectiveness of hemostatic agents. According to Brohi, coagulopathy is common in trauma patients and is augmented by hypothermia and hemodilution because of large amounts of IV fluid administration <xref rid="bib25" ref-type="bibr">[25]</xref>. Investigators have found several hemostatic agents are effective in hemorrhage control but often fail following IV crystalloid resuscitation. The failure may result from hemodilution or an increase in blood pressure or a combination <xref rid="bib2 bib3" ref-type="bibr">[2,3]</xref>. Few studies have investigated the effectiveness of hemostatic agents, specifically QCG in a hemodiluted or volume resuscitated state. In two separate studies, Johnson and colleagues found that QCG was effective in a resuscitated and hemodiluted state, but they did not examine the additional effects of hypothermia <xref rid="bib10 bib29" ref-type="bibr">[10,29]</xref>. Subsequently, Gegel and colleagues found that QCG was effective not only in hypothermia but also after IV resuscitation with 5&#x000a0;L of crystalloid fluid. However, these researchers did not investigate the effects of prior hemodilution. The clot had already formed when resuscitation fluid was administered and may not accurately reflect the effects of QCG in the presence of hemodilution <xref rid="bib24" ref-type="bibr">[24]</xref>.</p><p>The purposes of this study were to compare the effectiveness QCG to a control group on hemorrhage in a hemodiluted, hypothermic model, and to determine the amount of IV volume resuscitation on rebleeding. Specifically, this study was guided by the following research questions:<list list-type="simple"><list-item id="o0010"><label>1.</label><p>Is there a significant difference between QCG and control groups on hemorrhage in a porcine model of prior hemodilution and hypothermia?</p></list-item><list-item id="o0015"><label>2.</label><p>Is there a significant difference in the amount of IV crystalloid fluid administration before rebleeding between QCG and control occurs in a model of prior hemodilution and hypothermia?</p></list-item></list></p></sec><sec sec-type="methods" id="sec2"><label>2</label><title>Methods</title><p>This study was a prospective, between subjects, experimental design using a porcine model. The protocol was approved by the Institutional Animal Care and Use Committee (IACUC) that has a Public Health Service assurance number of A3345-01. All of the investigators completed the required Collaborative Institutional Training Initiative (CITI) animal care use modules. Furthermore, the animals received care in compliance with the Animal Welfare Act <xref rid="bib26" ref-type="bibr">[26]</xref>. The determination of effect size for this experiment was based upon previous work Gegel and Johnson <xref rid="bib11 bib19 bib24" ref-type="bibr">[11,19,24]</xref> Using data reported in those studies, the investigators calculated a large effect size of 0.6. Using an effect size of 0.6, a power of 0.80, and an alpha of 0.05, the researchers determined that 26 swine were needed for the study. The investigators used a computer randomized number generator to assign Yorkshire swine to either the QCG Group (<italic>n</italic>&#x000a0;=&#x000a0;13) or the Control Group (<italic>n</italic>&#x000a0;=&#x000a0;13). The mean weight of the swine was 70&#x000a0;kg (69.7&#x000a0;&#x000b1;&#x000a0;8.2 in QCG group; 72&#x000a0;&#x000b1;&#x000a0;11 in the control group), which represents the average weight of the US Army soldier <xref rid="bib27" ref-type="bibr">[27]</xref>. This study was conducted in 5 phases: induction/stabilization; exsanguination; hypothermia\hemodilution; hemorrhage; and fluid resuscitation.</p><sec id="sec2.1"><label>2.1</label><title>Induction/stabilization</title><p>The induction phase was initiated with an intramuscular injection of ketamine (20&#x000a0;mg/kg) and atropine (0.04&#x000a0;mg/kg). Subjects were placed supine on a litter followed by inhalation induction of isoflurane (4%&#x02013;5%). Following endotracheal intubation, the investigators inserted a peripheral IV catheter, and the isoflurane concentration was maintained between 1% and 2% for remainder of the experiment. The swine were ventilated with a Narkomed 2B anesthesia machine (Dr&#x000e4;ger, Telford, PA). Heart rate, electrocardiography, blood pressure, oxygen saturation, end-tidal carbon dioxide, and rectal temperature were continuously monitored throughout the experiment.</p><p>The left carotid artery was cannulated with a 20 gauge catheter using a cut-down technique. The arterial line was attached to a hemodynamic monitoring system (Hewlett Packard, Palo Alto, CA) for continuous monitoring of the arterial blood pressures. A central venous catheter was inserted in the subclavian vein using the modified Seldinger technique. The NPO fluid deficit was calculated using the Holliday-Segar formula, and the swine had replacement of the deficit with 0.9% normal saline. Activated clotting time (ACT) test, a common test to rule out preexisting coagulopathy, was used to screen all subjects.</p></sec><sec id="sec2.2"><label>2.2</label><title>Exsanguination/hypothermia/hemodilution phase</title><p>After the NPO deficit was replaced, 30% of the animal's blood volume was exsanguinated by gravity from the central line. Swine have the same volume of blood as humans (70&#x000a0;mL per kg); therefore, a pig that weighs 70&#x000a0;kg has 4900&#x000a0;mL of blood. Thirty percent of that volume is 1470&#x000a0;mL. A 3:1 replacement of Lactated Ringer's was administered to dilute the remaining blood. Hypothermia (temperature of &#x02264;34.0&#x000a0;&#x000b0;C) was induced by three methods: a cooling blanket, ice packs, and cold isopropyl alcohol spray. During this cooling period, the investigators created a complex groin injury, as described by Alam, to simulate a penetrating inguinal wound <xref rid="bib4 bib28" ref-type="bibr">[4,28]</xref>. The subjects were kept hypothermic for 10&#x000a0;min and stabilized for 30&#x000a0;min.</p></sec><sec id="sec2.3"><label>2.3</label><title>Hemorrhage phase</title><p>Following the 30&#x000a0;min stabilization period and 10&#x000a0;min of hypothermia, the investigators transected the femoral artery and vein. The swine were allowed to bleed for 1&#x000a0;min simulating the response time of a battlefield health care provider. Blood was collected through the use of 4&#x02033;&#x000a0;&#x000d7;&#x000a0;4&#x02033; gauze, absorbent pads placed underneath the animals, and by suction tip catheter placed in the distal portion of the wound per manufacturer's guidelines. After 1&#x000a0;min of uncontrolled hemorrhage, the investigators applied proximal pressure to the transected femoral vessels, and 4&#x02033;&#x000a0;&#x000d7;&#x000a0;4&#x02033; gauze was used to blot the blood from the wound. QCG was inserted into the wound making direct contact with the transected vessels. An overlying layer of petroleum gauze was applied to prevent adhesion of QCG to wound packing materials allowing for later dressing removal. Standard wound packing, using roller gauze (Covidien, Mansfield, MA.), was placed on top of the petroleum gauze layer until the wound cavity was filled. The control group received proximal pressure and the standard wound packing. Firm manual pressure of 25 pounds per square inch was applied for 5&#x000a0;min to the injury site as measured by a TIF electronic scale (Thermal Industries of Florida, Owaonna, MN) to both groups. The scale was placed between the litter and operating room table and zeroed in accordance with manufacturer's instructions. The rationale of using the TIF scale was so that consistent pressure could be applied and consistency between the swine could be maintained Five hundred mL of 6% hetastarch (Hospira, Inc., Lake Forest, IL) was administered to all subjects in accordance with current CTCCC recommendations. After 5&#x000a0;min of direct manual pressure, the investigators applied a 10&#x000a0;pound sandbag to the wound for an additional 30&#x000a0;min. The rationale for using a 10&#x000a0;pound sandbag was to simulate a pressure dressing. A sandbag would not be used on the battlefield, however, was used to maintain consistent pressure on the wounds of all subjects. After 35&#x000a0;min of pressure on the wound (5&#x000a0;min manual pressure plus 30&#x000a0;min with the sandbag), the standard pressure dressing was carefully removed with the goal of keeping the clot intact. Bleeding was observed. Hemostasis was operationally defined as clot formation with oozing of &#x02264;2% of the animal's total blood volume over a 5&#x000a0;min period (approximately 100&#x000a0;mL in a 70&#x000a0;kg swine). Blood loss was measured over 2 time periods: the initial injury to intervention and after the intervention and removal of the dressings. Blood loss was calculated by weighing the dressings, absorbent pads, and the blood suctioned from the distal portion of the wound.</p></sec><sec id="sec2.4"><label>2.4</label><title>High-volume crystalloid infusion phase</title><p>For the swine achieving hemostasis, the clot was further challenged with 5&#x000a0;L of IV crystalloid solution rapidly administered through the central venous catheter over 5&#x000a0;min. If rebleeding occurred during crystalloid infusion, the amount of IV fluid administered was determined, and the experiment was terminated. Hemorrhage was again observed for 5&#x000a0;min. If hemorrhage occurred or did not occur after 5&#x000a0;min, the study was terminated. It was expected to have some oozing of blood; therefore, hemorrhage was operationally defined as &#x0003e;2% total blood volume.</p></sec></sec><sec sec-type="results" id="sec3"><label>3</label><title>Results</title><p>There were no statistically significant differences in pre-intervention data between the groups relative to ACTs, body weights, core body temperatures, amount of 1&#x000a0;min hemorrhage, arterial blood pressures, pulse, MAP, blood volume, amount of NPO fluid deficit, amount of fluid resuscitation, or the amount of initial hemorrhage (<italic>p</italic>&#x000a0;=&#x000a0;.376). These results indicate the groups were equivalent on all these pre-intervention parameters. The ACT was within normal limits for all subjects. (See <xref rid="tbl1 tbl2" ref-type="table">Tables&#x000a0;1 and 2</xref> for a summary of selected pre-interventional data. Results are reported in means and standard deviations. In the parentheses are the ranges for each parameter).</p><p>A multivariate analysis of variance (MANOVA), Wilk's Lambda, determined there were significant differences in hemorrhage over a 5&#x000a0;min period and the amount of resuscitation fluid administered before rebleeding occurred (<italic>p</italic>&#x000a0;=&#x000a0;.001). A post-hoc Least Significant Difference (LSD) was used to determine where the significant differences were. The amount of hemorrhage in the QCG (<italic>M</italic>&#x000a0;=&#x000a0;30&#x000a0;&#x000b1;&#x000a0;99; range from 0 to 360&#x000a0;mL) was significantly less compared to the control (<italic>M</italic>&#x000a0;=&#x000a0;404&#x000a0;&#x000b1;&#x000a0;406; range from 0 to 1040&#x000a0;mL) (<italic>p</italic>&#x000a0;=&#x000a0;.004). Eleven of the 13 GCG swine had hemostasis compared to 4 of the 13 in the control group. A chi-square test indicated that the QCG group had significant less failures than the control group (<italic>p</italic>&#x000a0;=&#x000a0;0.018). Also, the amount of resuscitation fluid administered before rebleeding was significantly more in the QCG group (<italic>M</italic>&#x000a0;=&#x000a0;4115&#x000a0;&#x000b1;&#x000a0;1387&#x000a0;mL; range from 0 to 5000&#x000a0;mL) compared to the control group (<italic>M</italic>&#x000a0;=&#x000a0;846&#x000a0;&#x000b1;&#x000a0;1864&#x000a0;mL; range 0&#x02013;5000&#x000a0;mL) (<italic>p</italic>&#x000a0;=&#x000a0;.001). (See <xref rid="tbl3" ref-type="table">Table&#x000a0;3</xref> for a summary).</p></sec><sec sec-type="discussion" id="sec4"><label>4</label><title>Discussion</title><p>QCG is currently used by the US military and in many civilian sectors for management of massive hemorrhage in trauma casualties. The CTCCC recommends QCG as the first-line hemostatic agent for use in treatment of severe hemorrhage <xref rid="bib9" ref-type="bibr">[9]</xref>. The findings of this study support that recommendation. Further, the results support the investigators' previous research that QCG is effective in a hypothermic, resuscitated model <xref rid="bib23" ref-type="bibr">[23]</xref>. In addition, QCG is used by civilians as well as the military, and results of this study indicates it can be used in treatment of severe hemorrhage that cannot be controlled by a tourniquet regardless of the cause of the injury: gunshot, knife, or car accident. The cost of QCG is competitive and ranges from $30.00 to $48.00.</p><p>Clinicians and researchers have emphasized the metabolic benefit of replenishing the oxygen debt with volume resuscitation accumulated during hemorrhage <xref rid="bib23 bib29" ref-type="bibr">[23,29]</xref>. However, these benefits must be weighed against the deleterious effects of rebleeding. Continuing hemorrhage associated with rebleeding results in increased complications, morbidity and mortality <xref rid="bib1 bib2 bib30 bib31" ref-type="bibr">[1,2,30,31]</xref>. Therefore, the US military and the CTCCC advocate permissive hypotension. Specifically, the use of low-volume resuscitation in trauma casualties until definitive hemorrhage control is achieved <xref rid="bib9" ref-type="bibr">[9]</xref>. In previous studies, the investigators of this study found that QCG produced a more robust clot maintaining hemorrhage control during fluid resuscitation and with hemodilution <xref rid="bib11 bib19 bib32" ref-type="bibr">[11,19,32]</xref>. This study adds to a limited body of knowledge on the efficacy of hemostatic agents and compliments previous investigations relative to the use of QCG. This study suggests that QCG is more effective at hemorrhage control allowing more intravenous volume resuscitation to be administered before rebleeding compared to a standard pressure dressing in a porcine model of prior hemodilution and hypothermia. This study not only compliments previous findings relative to the use of QCG but adds to the body of knowledge in that the agent is more effective than a standard pressure dressing in prior hemodilution and hypothermia. The findings also suggest that when QCG is used, the clinician has more latitude with fluid resuscitation. Specifically, those treated with QCG could tolerate more fluid compared to a control before rebleeding occurred. The study has some limitations. The study had a relatively small sample size and should be replicated with a larger sample size, and the investigators were not blinded to group assignment. The research was implemented with a swine model and may not be generalizable to humans; however, the swine are similar in anatomy and physiology to humans <xref rid="bib33" ref-type="bibr">[33]</xref>.</p><p>Pusateri outlined the ideal qualities of hemostatic agents for civilian and military use (See <xref rid="tbl4" ref-type="table">Table&#x000a0;4</xref>) <xref rid="bib34" ref-type="bibr">[34]</xref>. QCG meets each of one of these criteria. Specifically, QCG is effective at hemorrhage control. It is packaged for immediate use in a waterproof vacuum-sealed pouch allowing it to be carried and deployed easily by physicians, nurses, medics, and ordinary citizens in emergency situations. In addition, QCG is approved by the FDA with a long shelf life of 3 years. There are no reports of serious side effects, exothermic reactions, or emboli formation <xref rid="bib13 bib34 bib35" ref-type="bibr">[13,34,35]</xref>. Last, the cost for QCG is relatively inexpensive and comparable to other hemostatic agents marketed in the US <xref rid="bib9" ref-type="bibr">[9]</xref>. Based on this study and the criteria outlined by Pusateri, QCG is an effective hemostatic agent for use in trauma management.</p></sec><sec id="sec5"><title>Conflicts of interest statement</title><p>None of the authors have any financial and personal relationships with QuikClot Combat Gauze (Z-Medica, Wallingford, CT).</p></sec><sec id="sec6"><title>Funding source</title><p>This study was funded by TriService Nursing Research Program (TSNRP).</p></sec><sec id="sec7"><title>Author involvement</title><p>All of the authors were involved in the design of the study. In addition, all authors collected and analyzed data and wrote and reviewed the manuscript.</p></sec></body><back><ref-list><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Sauaia</surname><given-names>A.</given-names></name><name><surname>Moore</surname><given-names>F.A.</given-names></name><name><surname>Moore</surname><given-names>E.E.</given-names></name><name><surname>Moser</surname><given-names>K.S.</given-names></name><name><surname>Brennan</surname><given-names>R.</given-names></name><name><surname>Read</surname><given-names>R.A.</given-names></name></person-group><article-title>Epidemiology of trauma deaths: a reassessment</article-title><source>J&#x000a0;Trauma</source><volume>38</volume><issue>2</issue><year>1995 Feb</year><fpage>185</fpage><lpage>193</lpage><comment>PubMed PMID: 7869433</comment><pub-id pub-id-type="pmid">7869433</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>H.B.</given-names></name><name><surname>Burris</surname><given-names>D.</given-names></name><name><surname>DaCorta</surname><given-names>J.A.</given-names></name><name><surname>Rhee</surname><given-names>P.</given-names></name></person-group><article-title>Hemorrhage control in the battlefield: role of new hemostatic agents</article-title><source>Mil Med</source><volume>170</volume><issue>1</issue><year>2005 Jan</year><fpage>63</fpage><lpage>69</lpage><comment>PubMed PMID: 15724857</comment><pub-id pub-id-type="pmid">15724857</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>H.B.</given-names></name><name><surname>Koustova</surname><given-names>E.</given-names></name><name><surname>Rhee</surname><given-names>P.</given-names></name></person-group><article-title>Combat casualty care research: from bench to the battlefield</article-title><source>World J Surg</source><volume>29</volume><issue>Suppl.&#x000a0;1</issue><year>2005</year><fpage>S7</fpage><lpage>S11</lpage><comment>PubMed PMID: 15815839</comment><pub-id pub-id-type="pmid">15815839</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>H.B.</given-names></name><name><surname>Uy</surname><given-names>G.B.</given-names></name><name><surname>Miller</surname><given-names>D.</given-names></name><name><surname>Koustova</surname><given-names>E.</given-names></name><name><surname>Hancock</surname><given-names>T.</given-names></name><name><surname>Inocencio</surname><given-names>R.</given-names></name></person-group><article-title>Comparative analysis of hemostatic agents in a swine model of lethal groin injury</article-title><source>J&#x000a0;Trauma</source><volume>54</volume><issue>6</issue><year>2003 Jun</year><fpage>1077</fpage><lpage>1082</lpage><comment>PubMed PMID: 12813325</comment><pub-id pub-id-type="pmid">12813325</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Mabry</surname><given-names>R.L.</given-names></name><name><surname>Holcomb</surname><given-names>J.B.</given-names></name><name><surname>Baker</surname><given-names>A.M.</given-names></name><name><surname>Cloonan</surname><given-names>C.C.</given-names></name><name><surname>Uhorchak</surname><given-names>J.M.</given-names></name><name><surname>Perkins</surname><given-names>D.E.</given-names></name></person-group><article-title>United States Army Rangers in Somalia: an analysis of combat casualties on an urban battlefield</article-title><source>J&#x000a0;Trauma</source><volume>49</volume><issue>3</issue><year>2000 Sep</year><fpage>515</fpage><lpage>528</lpage><comment>discussion 28-9. PubMed PMID: 11003332. Epub 2000/09/26. eng</comment><pub-id pub-id-type="pmid">11003332</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Champion</surname><given-names>H.R.</given-names></name><name><surname>Bellamy</surname><given-names>R.F.</given-names></name><name><surname>Roberts</surname><given-names>C.P.</given-names></name><name><surname>Leppaniemi</surname><given-names>A.</given-names></name></person-group><article-title>A&#x000a0;profile of combat injury</article-title><source>J&#x000a0;Trauma</source><volume>54</volume><issue>5 Suppl.</issue><year>2003 May</year><fpage>S13</fpage><lpage>S19</lpage><comment>PubMed PMID: 12768096. Epub 2003/05/28. eng</comment><pub-id pub-id-type="pmid">12768096</pub-id></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Hess</surname><given-names>J.R.</given-names></name><name><surname>Brohi</surname><given-names>K.</given-names></name><name><surname>Dutton</surname><given-names>R.P.</given-names></name><name><surname>Hauser</surname><given-names>C.J.</given-names></name><name><surname>Holcomb</surname><given-names>J.B.</given-names></name><name><surname>Kluger</surname><given-names>Y.</given-names></name></person-group><article-title>The coagulopathy of trauma: a review of mechanisms</article-title><source>J&#x000a0;Trauma</source><volume>65</volume><issue>4</issue><year>2008 Oct</year><fpage>748</fpage><lpage>754</lpage><comment>PubMed PMID: 18849786</comment><pub-id pub-id-type="pmid">18849786</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>K.R.</given-names></name><name><surname>Tiba</surname><given-names>M.H.</given-names></name><name><surname>Holbert</surname><given-names>W.H.</given-names></name><name><surname>Blocher</surname><given-names>C.R.</given-names></name><name><surname>Draucker</surname><given-names>G.T.</given-names></name><name><surname>Proffitt</surname><given-names>E.K.</given-names></name></person-group><article-title>Comparison of a new hemostatic agent to current combat hemostatic agents in a Swine model of lethal extremity arterial hemorrhage</article-title><source>J&#x000a0;Trauma</source><volume>63</volume><issue>2</issue><year>2007 Aug</year><fpage>276</fpage><lpage>283</lpage><comment>discussion 83-4. PubMed PMID: 17693824</comment><pub-id pub-id-type="pmid">17693824</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="book" id="sref9"><person-group person-group-type="author"><name><surname>Care CoTCC</surname></name></person-group><chapter-title>Tactical combat casualty care guidelines</chapter-title><year>2012</year><comment>November 30, 2013</comment></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="book" id="sref10"><person-group person-group-type="author"><name><surname>Z-Medica</surname></name></person-group><chapter-title>QuikClot Combat Gauze</chapter-title><year>2013</year><comment>[November 30, 2013]</comment><ext-link ext-link-type="uri" xlink:href="http://www.z-medica.com/healthcare/Home.aspx" id="intref0010">http://www.z-medica.com/healthcare/Home.aspx</ext-link></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>D.</given-names></name><name><surname>Agee</surname><given-names>S.</given-names></name><name><surname>Reed</surname><given-names>A.</given-names></name><name><surname>Gegel</surname><given-names>B.</given-names></name><name><surname>Burgert</surname><given-names>J.</given-names></name><name><surname>Gasko</surname><given-names>J.</given-names></name></person-group><article-title>The effects of QuikClot Combat Gauze on hemorrhage control in the presence of hemodilution</article-title><source>US Army Med Dep J</source><year>2012 Oct&#x02013;Dec</year><fpage>36</fpage><lpage>39</lpage><comment>PubMed PMID: 23007935</comment><pub-id pub-id-type="pmid">23007935</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Dubick</surname><given-names>M.A.</given-names></name><name><surname>Kheirabadi</surname><given-names>B.S.</given-names></name></person-group><article-title>Hemostyptic wound bandages: are there any differences?</article-title><source>Wiener klinische Wochenschrift</source><volume>122</volume><issue>Suppl.&#x000a0;5</issue><year>2010 Dec</year><fpage>S18</fpage><comment>PubMed PMID: 21598442</comment><pub-id pub-id-type="pmid">21598442</pub-id></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Kheirabadi</surname><given-names>B.S.</given-names></name><name><surname>Mace</surname><given-names>J.E.</given-names></name><name><surname>Terrazas</surname><given-names>I.B.</given-names></name><name><surname>Fedyk</surname><given-names>C.G.</given-names></name><name><surname>Estep</surname><given-names>J.S.</given-names></name><name><surname>Dubick</surname><given-names>M.A.</given-names></name></person-group><article-title>Safety evaluation of new hemostatic agents, smectite granules, and kaolin-coated gauze in a vascular injury wound model in swine</article-title><source>J&#x000a0;Trauma</source><volume>68</volume><issue>2</issue><year>2010 Feb</year><fpage>269</fpage><lpage>278</lpage><comment>PubMed PMID: 20154537</comment><pub-id pub-id-type="pmid">20154537</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Kheirabadi</surname><given-names>B.S.</given-names></name><name><surname>Scherer</surname><given-names>M.R.</given-names></name><name><surname>Estep</surname><given-names>J.S.</given-names></name><name><surname>Dubick</surname><given-names>M.A.</given-names></name><name><surname>Holcomb</surname><given-names>J.B.</given-names></name></person-group><article-title>Determination of efficacy of new hemostatic dressings in a model of extremity arterial hemorrhage in swine</article-title><source>J&#x000a0;Trauma</source><volume>67</volume><issue>3</issue><year>2009 Sep</year><fpage>450</fpage><lpage>459</lpage><comment>discussion 9-60. PubMed PMID: 19741385</comment><pub-id pub-id-type="pmid">19741385</pub-id></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Kheirabadi</surname><given-names>B.S.</given-names></name><name><surname>Edens</surname><given-names>J.W.</given-names></name><name><surname>Terrazas</surname><given-names>I.B.</given-names></name><name><surname>Estep</surname><given-names>J.S.</given-names></name><name><surname>Klemcke</surname><given-names>H.G.</given-names></name><name><surname>Dubick</surname><given-names>M.A.</given-names></name></person-group><article-title>Comparison of new hemostatic granules/powders with currently deployed hemostatic products in a lethal model of extremity arterial hemorrhage in swine</article-title><source>J&#x000a0;Trauma</source><volume>66</volume><issue>2</issue><year>2009 Feb</year><fpage>316</fpage><lpage>326</lpage><comment>discussion 27-8. PubMed PMID: 19204503</comment><pub-id pub-id-type="pmid">19204503</pub-id></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Arnaud</surname><given-names>F.</given-names></name><name><surname>Teranishi</surname><given-names>K.</given-names></name><name><surname>Okada</surname><given-names>T.</given-names></name><name><surname>Parreno-Sacdalan</surname><given-names>D.</given-names></name><name><surname>Hupalo</surname><given-names>D.</given-names></name><name><surname>McNamee</surname><given-names>G.</given-names></name></person-group><article-title>Comparison of Combat Gauze and TraumaStat in two severe groin injury models</article-title><source>J&#x000a0;Surg Res</source><volume>169</volume><issue>1</issue><year>2011 Jul</year><fpage>92</fpage><lpage>98</lpage><comment>PubMed PMID: 20070980</comment><pub-id pub-id-type="pmid">20070980</pub-id></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Arnaud</surname><given-names>F.</given-names></name><name><surname>Parreno-Sadalan</surname><given-names>D.</given-names></name><name><surname>Tomori</surname><given-names>T.</given-names></name><name><surname>Delima</surname><given-names>M.G.</given-names></name><name><surname>Teranishi</surname><given-names>K.</given-names></name><name><surname>Carr</surname><given-names>W.</given-names></name></person-group><article-title>Comparison of 10 hemostatic dressings in a groin transection model in swine</article-title><source>J&#x000a0;Trauma</source><volume>67</volume><issue>4</issue><year>2009 Oct</year><fpage>848</fpage><lpage>855</lpage><comment>PubMed PMID: 19820595</comment><pub-id pub-id-type="pmid">19820595</pub-id></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>R.B.</given-names></name><name><surname>Reynolds</surname><given-names>B.Z.</given-names></name><name><surname>Shiver</surname><given-names>S.A.</given-names></name><name><surname>Lerner</surname><given-names>E.B.</given-names></name><name><surname>Greenfield</surname><given-names>E.M.</given-names></name><name><surname>Solis</surname><given-names>R.A.</given-names></name></person-group><article-title>Comparison of two packable hemostatic Gauze dressings in a porcine hemorrhage model</article-title><source>Prehosp Emerg Care Off J Natl Assoc EMS Phys Natl Assoc State EMS Dir</source><volume>15</volume><issue>4</issue><year>2011 Oct&#x02013;Dec</year><fpage>477</fpage><lpage>482</lpage><comment>PubMed PMID: 21870945</comment></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Gegel</surname><given-names>B.</given-names></name><name><surname>Burgert</surname><given-names>J.</given-names></name><name><surname>Gasko</surname><given-names>J.</given-names></name><name><surname>Campbell</surname><given-names>C.</given-names></name><name><surname>Martens</surname><given-names>M.</given-names></name><name><surname>Keck</surname><given-names>J.</given-names></name></person-group><article-title>The effects of QuikClot Combat Gauze and movement on hemorrhage control in a porcine model</article-title><source>Mil Med</source><volume>177</volume><issue>12</issue><year>2012 Dec</year><fpage>1543</fpage><lpage>1547</lpage><comment>PubMed PMID: 23397703</comment><pub-id pub-id-type="pmid">23397703</pub-id></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Burgert</surname><given-names>J.</given-names></name><name><surname>Gegel</surname><given-names>B.</given-names></name><name><surname>Loughren</surname><given-names>M.</given-names></name><name><surname>Ceremuga</surname><given-names>T.</given-names></name><name><surname>Desai</surname><given-names>M.</given-names></name><name><surname>Schlicher</surname><given-names>M.</given-names></name></person-group><article-title>Comparison of tibial intraosseous, sternal intraosseous, and intravenous routes of administration on pharmacokinetics of epinephrine during cardiac arrest: a pilot study</article-title><source>AANA J</source><volume>80</volume><issue>4 Suppl.</issue><year>2012 Aug</year><fpage>S6</fpage><lpage>S10</lpage><comment>PubMed PMID: 23248824</comment><pub-id pub-id-type="pmid">23248824</pub-id></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>T.D.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Reed</surname><given-names>R.L.</given-names><suffix>2nd</suffix></name></person-group><article-title>Functional equivalence of hypothermia to specific clotting factor deficiencies</article-title><source>J&#x000a0;Trauma</source><volume>37</volume><issue>3</issue><year>1994 Sep</year><fpage>413</fpage><lpage>417</lpage><comment>PubMed PMID: 8083902. Epub 1994/09/01. eng</comment><pub-id pub-id-type="pmid">8083902</pub-id></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Soreide</surname><given-names>K.</given-names></name></person-group><article-title>Clinical and translational aspects of hypothermia in major trauma patients: from pathophysiology to prevention, prognosis and potential preservation</article-title><source>Injury</source><volume>45</volume><year>2014</year><fpage>647</fpage><lpage>654</lpage><pub-id pub-id-type="pmid">23352151</pub-id></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Arthurs</surname><given-names>Z.</given-names></name><name><surname>Cuadrado</surname><given-names>D.</given-names></name><name><surname>Beekley</surname><given-names>A.</given-names></name><name><surname>Grathwohl</surname><given-names>K.</given-names></name><name><surname>Perkins</surname><given-names>J.</given-names></name><name><surname>Rush</surname><given-names>R.</given-names></name></person-group><article-title>The impact of hypothermia on trauma care at the 31st combat support hospital</article-title><source>Am J Surg</source><volume>191</volume><issue>5</issue><year>2006 May</year><fpage>610</fpage><lpage>614</lpage><comment>PubMed PMID: 16647346</comment><pub-id pub-id-type="pmid">16647346</pub-id></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Brian Gegel</surname><given-names>J.B.</given-names></name><name><surname>John Gasko</surname></name><name><surname>Johnson</surname><given-names>Sabine</given-names></name><name><surname>Florez</surname><given-names>Jennifer</given-names></name><name><surname>Edward Dunton</surname><given-names>E.</given-names><suffix>II</suffix></name><name><surname>Johnson</surname><given-names>Don</given-names></name></person-group><article-title>The efficacy of QuikClot combat gauze, fluid resuscitation and movement on hemorrhage control in a porcine model of hypothermia</article-title><source>Br J Med Res</source><volume>4</volume><issue>7</issue><year>2014</year><fpage>1483</fpage><lpage>1493</lpage></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Brohi</surname><given-names>K.</given-names></name><name><surname>Singh</surname><given-names>J.</given-names></name><name><surname>Heron</surname><given-names>M.</given-names></name><name><surname>Coats</surname><given-names>T.</given-names></name></person-group><article-title>Acute traumatic coagulopathy</article-title><source>J&#x000a0;Trauma</source><volume>54</volume><issue>6</issue><year>2003 Jun</year><fpage>1127</fpage><lpage>1130</lpage><comment>PubMed PMID: 12813333</comment><pub-id pub-id-type="pmid">12813333</pub-id></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="book" id="sref26"><person-group person-group-type="author"><name><surname>Council NR</surname></name></person-group><chapter-title>Guide for the care and use of laboratory animals</chapter-title><edition>8th ed.</edition><year>2011</year><publisher-name>National Academies Press</publisher-name></element-citation></ref><ref id="bib27"><label>27</label><mixed-citation publication-type="other" id="oref1">US Army. Available from: <ext-link ext-link-type="uri" xlink:href="http://ioe.engin.umich.edu/ioe491/AnthroData.html" id="intref0015">http://ioe.engin.umich.edu/ioe491/AnthroData.html</ext-link>, accessed October 22. US Army Anthropometric Data Sets 2007.</mixed-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>H.B.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Jaskille</surname><given-names>A.</given-names></name><name><surname>Querol</surname><given-names>R.I.</given-names></name><name><surname>Koustova</surname><given-names>E.</given-names></name><name><surname>Inocencio</surname><given-names>R.</given-names></name></person-group><article-title>Application of a zeolite hemostatic agent achieves 100% survival in a lethal model of complex groin injury in Swine</article-title><source>J&#x000a0;Trauma</source><volume>56</volume><issue>5</issue><year>2004 May</year><fpage>974</fpage><lpage>983</lpage><comment>PubMed PMID: 15179235. Epub 2004/06/05. eng</comment><pub-id pub-id-type="pmid">15179235</pub-id></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Santibanez-Gallerani</surname><given-names>A.S.</given-names></name><name><surname>Barber</surname><given-names>A.E.</given-names></name><name><surname>Williams</surname><given-names>S.J.</given-names></name><name><surname>Zhao</surname><given-names>B.S.Y.</given-names></name><name><surname>Shires</surname><given-names>G.T.</given-names></name></person-group><article-title>Improved survival with early fluid resuscitation following hemorrhagic shock</article-title><source>World J Surg</source><volume>25</volume><issue>5</issue><year>2001 May</year><fpage>592</fpage><lpage>597</lpage><comment>PubMed PMID: 11369985</comment><pub-id pub-id-type="pmid">11369985</pub-id></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Cosgriff</surname><given-names>N.</given-names></name><name><surname>Moore</surname><given-names>E.E.</given-names></name><name><surname>Sauaia</surname><given-names>A.</given-names></name><name><surname>Kenny-Moynihan</surname><given-names>M.</given-names></name><name><surname>Burch</surname><given-names>J.M.</given-names></name><name><surname>Galloway</surname><given-names>B.</given-names></name></person-group><article-title>Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited</article-title><source>J&#x000a0;Trauma</source><volume>42</volume><issue>5</issue><year>1997 May</year><fpage>857</fpage><lpage>861</lpage><comment>discussion 61-2. PubMed PMID: 9191667</comment><pub-id pub-id-type="pmid">9191667</pub-id></element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Heckbert</surname><given-names>S.R.</given-names></name><name><surname>Vedder</surname><given-names>N.B.</given-names></name><name><surname>Hoffman</surname><given-names>W.</given-names></name><name><surname>Winn</surname><given-names>R.K.</given-names></name><name><surname>Hudson</surname><given-names>L.D.</given-names></name><name><surname>Jurkovich</surname><given-names>G.J.</given-names></name></person-group><article-title>Outcome after hemorrhagic shock in trauma patients</article-title><source>J&#x000a0;Trauma</source><volume>45</volume><issue>3</issue><year>1998 Sep</year><fpage>545</fpage><lpage>549</lpage><comment>PubMed PMID: 9751548</comment><pub-id pub-id-type="pmid">9751548</pub-id></element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Don Johnson</surname><given-names>B.G.</given-names></name><name><surname>Burgert</surname><given-names>James</given-names></name><name><surname>Gasko</surname><given-names>John</given-names></name><name><surname>Cromwell</surname><given-names>Carrie</given-names></name><name><surname>Jaskowska</surname><given-names>Monika</given-names></name><name><surname>Steward</surname><given-names>Rachel</given-names></name></person-group><article-title>The effects of QuikClot Combat Gauze, fluid resuscitation and movement on hemorrhage control in a porcine model</article-title><source>ISRN Emerg Med</source><volume>2012</volume><year>2012</year><fpage>1</fpage><lpage>6</lpage><comment>(Article ID 927678:)</comment></element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Mader</surname><given-names>T.J.</given-names></name><name><surname>Kellogg</surname><given-names>A.R.</given-names></name><name><surname>Smith</surname><given-names>J.</given-names></name><name><surname>Hynds-Decoteau</surname><given-names>R.</given-names></name><name><surname>Gaudet</surname><given-names>C.</given-names></name><name><surname>Caron</surname><given-names>J.</given-names></name></person-group><article-title>A&#x000a0;blinded, randomized controlled evaluation of an impedance threshold device during cardiopulmonary resuscitation in swine</article-title><source>Resuscitation</source><volume>77</volume><issue>3</issue><year>2008 Jun</year><fpage>387</fpage><lpage>394</lpage><comment>PubMed PMID: 18308451</comment><pub-id pub-id-type="pmid">18308451</pub-id></element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Pusateri</surname><given-names>A.E.</given-names></name><name><surname>Holcomb</surname><given-names>J.B.</given-names></name><name><surname>Kheirabadi</surname><given-names>B.S.</given-names></name><name><surname>Alam</surname><given-names>H.B.</given-names></name><name><surname>Wade</surname><given-names>C.E.</given-names></name><name><surname>Ryan</surname><given-names>K.L.</given-names></name></person-group><article-title>Making sense of the preclinical literature on advanced hemostatic products</article-title><source>J&#x000a0;Trauma</source><volume>60</volume><issue>3</issue><year>2006 Mar</year><fpage>674</fpage><lpage>682</lpage><comment>PubMed PMID: 16531876</comment><pub-id pub-id-type="pmid">16531876</pub-id></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Gerlach</surname><given-names>T.</given-names></name><name><surname>Grayson</surname><given-names>J.K.</given-names></name><name><surname>Pichakron</surname><given-names>K.O.</given-names></name><name><surname>Sena</surname><given-names>M.J.</given-names></name><name><surname>DeMartini</surname><given-names>S.D.</given-names></name><name><surname>Clark</surname><given-names>B.Z.</given-names></name></person-group><article-title>Preliminary study of the effects of smectite granules (WoundStat) on vascular repair and wound healing in a swine survival model</article-title><source>J&#x000a0;Trauma</source><volume>69</volume><issue>5</issue><year>2010 Nov</year><fpage>1203</fpage><lpage>1209</lpage><comment>PubMed PMID: 20068476</comment><pub-id pub-id-type="pmid">20068476</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="tbl1" position="float"><label>Table&#x000a0;1</label><caption><p>Pre-interventional data.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Group</th><th>Weight in kg</th><th>ACT</th><th>Hours NPO</th><th>NPO deficit in mL</th><th>Blood volume in mL</th></tr></thead><tbody><tr><td>QCG</td><td align="char">69.7&#x000a0;&#x000b1;&#x000a0;8.2 (60.9&#x02013;86.4)</td><td align="char">111.2&#x000a0;&#x000b1;&#x000a0;16.9 (69&#x02013;138)</td><td align="char">9.4&#x000a0;&#x000b1;&#x000a0;1.4 (8&#x02013;13)</td><td align="char">1045&#x000a0;&#x000b1;&#x000a0;170 (814&#x02013;1442)</td><td align="char">4796&#x000a0;&#x000b1;&#x000a0;690 (3500&#x02013;6045)</td></tr><tr><td>Control</td><td align="char">72&#x000a0;&#x000b1;&#x000a0;11 (45.5&#x02013;91.4)</td><td align="char">107.6&#x000a0;&#x000b1;&#x000a0;15.3 (79&#x02013;137)</td><td align="char">10.4&#x000a0;&#x000b1;&#x000a0;1.7 (8&#x02013;13)</td><td align="char">1158&#x000a0;&#x000b1;&#x000a0;168 (898&#x02013;1451)</td><td align="char">5042&#x000a0;&#x000b1;&#x000a0;771 (3182&#x02013;6395)</td></tr></tbody></table></table-wrap><table-wrap id="tbl2" position="float"><label>Table&#x000a0;2</label><caption><p>Pre-interventional data continued.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Group</th><th>30% Exsanguination in mL</th><th>Replacement in mL</th><th>Amount of 1 minute hemorrhage in mL</th><th>Temperature at hemorrhage in degrees Celsius</th></tr></thead><tbody><tr><td>QCG</td><td align="char">1469&#x000a0;&#x000b1;&#x000a0;170 (1279&#x02013;1814)</td><td align="char">4321&#x000a0;&#x000b1;&#x000a0;616 (3179&#x02013;5441)</td><td align="char">794&#x000a0;&#x000b1;&#x000a0;396 (271&#x02013;1440)</td><td align="char">32.9&#x000a0;&#x000b1;&#x000a0;0.70 (32&#x02013;34)</td></tr><tr><td>Control</td><td align="char">1512&#x000a0;&#x000b1;&#x000a0;231 (955&#x02013;1919)</td><td align="char">4537&#x000a0;&#x000b1;&#x000a0;694 (2864&#x02013;5756)</td><td align="char">1042&#x000a0;&#x000b1;&#x000a0;562 (288&#x02013;2260)</td><td align="char">33.5&#x000a0;&#x000b1;&#x000a0;0.36 (32&#x02013;34)</td></tr></tbody></table></table-wrap><table-wrap id="tbl3" position="float"><label>Table&#x000a0;3</label><caption><p>Summary of findings.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Group</th><th>Amount of hemorrhage in mL</th><th>Number and percent with hemostasis</th><th><italic>p</italic> Values relative to hemorrhage</th><th><italic>p</italic> Values relative to hemostasis</th></tr></thead><tbody><tr><td>QCG</td><td>30&#x000a0;&#x000b1;&#x000a0;99; range from 0 to 360&#x000a0;mL</td><td>11 out 13 (84.6% success)</td><td rowspan="2">(<italic>p</italic>&#x000a0;=&#x000a0;0.001)* The QCG group had significantly less hemorrhage than the control group.</td><td rowspan="2">(<italic>p</italic>&#x000a0;=&#x000a0;0.018)* QCG had significantly less failures compared to the control group.</td></tr><tr><td>Control</td><td>404&#x000a0;&#x000b1;&#x000a0;406; range from 0 to 1040&#x000a0;mL</td><td>4 out 13 (30.8% success)</td></tr></tbody></table><table-wrap-foot><fn><p>*Significant at the 0.05.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl4" position="float"><label>Table&#x000a0;4</label><caption><p>The ideal qualities of pre-hospital hemostatic agents.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td>1. The ability to rapidly stop large vessel arterial and venous bleeding within 2&#x000a0;min through a pool of blood.</td></tr><tr><td>2. No requirement for mixing or pre-application preparation.</td></tr><tr><td>3. Simplicity of application by wounded victim, buddy or medic.</td></tr><tr><td>4. Light weight and durable.</td></tr><tr><td>5. Long shelf life greater than 2 years in extreme environments.</td></tr><tr><td>6. Safe to use with no risk of injury to tissues or transmission of infection.</td></tr><tr><td>7. Inexpensive.</td></tr></tbody></table></table-wrap></floats-group></article>